FIELD: biotechnology.
SUBSTANCE: invention relates to a nucleic acid molecule which encodes an amino acid chain capable of forming a dimeric protein and to the said dimeric protein. The said dimeric protein is used as a vaccine. It contains two identical amino acid chains, each containing a targeting group - humanα MIP1 - and an antigenic group connected by the motif for dimerization. This invention also discloses a pharmaceutical composition and a vaccine against the malignancy, comprising the said dimeric protein or nucleic acid molecule and a host cell and a method for production of the said dimeric protein. Due to human MIP1 application as the targeting group toα deliver the antigen to antigen presenting cells, this invention allows to produce a vaccines inducing the antigen-specific CD8+T-cell response.
EFFECT: possibility of obtaining a vaccine.
92 cl, 9 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINES AGAINST HPV | 2012 |
|
RU2644201C2 |
| YEAST-BASED IMMUNOTHERAPEUTIC COMPOSITIONS WITH BRACHYURY | 2012 |
|
RU2690180C2 |
| IMMUNOTHERAPEUTIC COMPOSITIONS BASED ON YEAST WITH BRACHYURY | 2012 |
|
RU2619850C2 |
| CONJUGATES AND COMPOSITIONS FOR IMMUNOTHERAPY AND ANTICANCER TREATMENT | 2010 |
|
RU2597989C2 |
| POLYPEPTIDES AND POLYNUCLEOTIDES AND THEIR USE FOR TREATMENT OF IMMUNE DISORDERS AND CANCER | 2012 |
|
RU2623161C2 |
| MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS BASED THEREON AND THEIR APPLICATION | 2012 |
|
RU2632651C2 |
| COVALENT DIANTIBODIES AND USE THEREOF | 2009 |
|
RU2593720C2 |
| ANTIBODIES TO PROGRAMMED CELL DEATH PROTEIN 1 | 2018 |
|
RU2812915C2 |
| MULTIVALENT VACCINE AGAINST BREAST CANCER | 2013 |
|
RU2645085C2 |
| COMPOSITION AND IMMUNIZATION METHOD, METHODS FOR PRODUCING NON-NATURAL, ORDERED AND REPEATED ANTIGEN MASSIVE AND COAT PROTEIN | 2002 |
|
RU2295973C2 |
